Trial intelligence / Profile preview

Phase II trial of Neu2000KWL in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia

KCT0007235Phase 2Recruiting

Sponsor
GNT Pharma
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cardiac arrest (SCA) comparing Neu2000KWL arm with Placebo arm (2 arms). Started Nov 2018; status: recruiting.

02

Drugs

salfaprodil
03

Conditions

cardiac arrest (SCA)

Beyond the preview

Go deeper on KCT0007235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0007235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call